BOULDER, Colo., Feb. 7, 2018 /PRNewswire/ -- Array BioPharma Inc.
(Nasdaq: ARRY) today announced that its Chief Executive Officer,
Ron Squarer, will speak at the
LEERINK Partners 7th Annual Global Healthcare Conference
in New York. The public is welcome to participate in the
conference through a webcast on the Array BioPharma
website.
Event:
|
LEERINK Partners
Annual Global Healthcare Conference
|
Presenter:
|
Ron Squarer, Chief
Executive Officer, Array BioPharma
|
Date:
|
Wednesday, February
14, 2018
|
Time:
|
1:30 p.m. Eastern
Time
|
Webcast:
|
http://wsw.com/webcast/leerink30/arry/
|
About Array BioPharma
Array BioPharma Inc. is a
biopharmaceutical company focused on the discovery, development and
commercialization of targeted small molecule drugs to treat
patients afflicted with cancer. Nine registration studies are
currently advancing related to seven Array-owned or partnered
drugs: binimetinib (MEK162), encorafenib (LGX818), selumetinib
(partnered with AstraZeneca), danoprevir (partnered with Roche),
ipatasertib (partnered with Genentech), larotrectinib (partnered
with Loxo Oncology) and tucatinib (partnered with Cascadian
Therapeutics). For more information on Array, please go to
www.arraybiopharma.com.
CONTACT:
Andrea N. Flynn, Ph.D.
Senior Director, Investor Relations & Corporate
Communications
(303) 381-6600
ir@arraybiopharma.com
View original content with
multimedia:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-leerink-partners-7th-annual-global-healthcare-conference-300595364.html
SOURCE Array BioPharma Inc.